1-5 of 5
gastric ulcer perforation
Close
Sort by
Journal Articles

Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)

Rajat Bannerji, MD PhD, John N. Allan, MD, Jon E. Arnason, MD, Jennifer R. Brown, MD PhD, Ranjana H Advani, MD, Jeffrey A. Barnes, MD PhD, Stephen M Ansell, MD PhD, Susan M. O'Brien, MD, Julio Chavez, Johannes Duell, MD, Kevin A. David, MD, Peter Martin, FRCPC, MD MS, Robin M. Joyce, MD, Robert Charnas, PhD, Srikanth R. Ambati, MBBS, MD, Lieve Adriaens, PharmD, Melanie Ufkin, PhD, Min Zhu, PhD, Jingjin Li, PhD, Peter Gasparini, MS, Anfal Ibrahim, BS, Vladimir Jankovic, MD, Nathalie Fiaschi, PhD, Olulanu Aina, PhD, Wen Zhang, PhD, Raquel P. Deering, PhD, Sara Hamon, PhD, Gavin Thurston, PhD, Andrew J. Murphy, PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Israel Lowy, MD PhD, David Sternberg, MD PhD, Max S. Topp, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 762.
https://doi.org/10.1182/blood-2019-122451
Published: 2019
Journal Articles

Rapid Dose Escalation of Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with B-Cell Receptor Inhibitor Therapy

Kristin Koenig, MD, Emily Dotson, PharmD, Shane Sheredy, Seema A. Bhat, MD, John C. Byrd, MD, Tracy Wiczer, Jennifer Woyach, MD, Farrukh T. Awan, MD, Kerry A. Rogers, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3045.
https://doi.org/10.1182/blood-2019-124538
Published: 2019
Journal Articles

The Addition of Rituximab to Chemotherapy Decreased Rates of Primary Surgery for Gastric Diffuse Large B-Cell Lymphoma without Increasing Early Mortality

Eric Wiedower, DO, Smith Giri, MBBS, Andrew Fintel, DO, Philip Prouet, MD, Elena Paulus, MD, Jason C. Chandler, MD, Mike G. Martin, MD
Journal: Blood
Blood (2015) 126 (23): 4475.
https://doi.org/10.1182/blood.V126.23.4475.4475
Published: 2015
Journal Articles

Surgical Complications in Patients Treated with Chemotherapy for Gastric Diffuse Large B Cell Lymphoma.

Galia Spectre, MD, Diana Libster, MD, Sigal Grisariu, MD, Nael Da’as, MD, Zvi Gimmon, MD, Ora Paltiel, MDCM
Journal: Blood
Blood (2005) 106 (11): 4732.
https://doi.org/10.1182/blood.V106.11.4732.4732
Published: 2005
Journal Articles

Rituximab Does Not Increase the Complication Rate, Particularly Perforation, When Added to Chemotherapy for Patients with Primary B-Cell Lymphomas of the Gastrointestinal Tract.

Shireen A. Kassam, MRCP, Anthony H. Goldstone, FRCP, A. V. Hoffbrand, FRCP, Miguel Perez-Machado, MBBS, Nicola Cooper, MRCP, Panos Kottaridis, MRCP, Archie Prentice, FRCP, Derralyn Hughes, MRCP, Christopher J. McNamara, FRACP, FRCPA
Journal: Blood
Blood (2005) 106 (11): 4742.
https://doi.org/10.1182/blood.V106.11.4742.4742
Published: 2005